Ginkgo Bioworks Holdings (DNA) Other Working Capital Changes (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Other Working Capital Changes data on file, last reported at -$2.6 million in Q1 2026.

• Quarterly Other Working Capital Changes rose 80.24% year-over-year to -$2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.8 million (down 211.6% YoY) and the FY2025 annual result came in at -$32.4 million, down 1646.94% from the prior year.
• Other Working Capital Changes grew to -$2.6 million in Q1 2026, from -$13.6 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $13.8 million in Q4 2022 to a low of -$7.4 million in Q1 2023.
• A 5-year average of -$748117.6 and a median of -$1.2 million in 2024 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes tumbled 13095.6% — and 2024, when it surged 1656.19%.
• Tracing DNA's Other Working Capital Changes over 5 years: stood at -$36.5 million in 2022, then soared by 87.7% to -$4.5 million in 2023, then surged by 1656.19% to $69.9 million in 2024, then sank by 119.46% to -$13.6 million in 2025, then soared by 80.84% to -$2.6 million in 2026.
• The last three Other Working Capital Changes figures came in at -$2.6 million (Q1 2026), -$13.6 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.